The purpose of this program in viral oncology is to continue support for the training of five fellows at the predoctoral level and five fellows at the postdoctoral level in viral oncology. Training in this program will encompass molecular biology, genetics and oncogenic transformation mechanisms of a number of transforming viruses, as well as other viruses either involved in human disease or used for human disease models or gene transfer. Additionally, training will be offered in the molecular and cellular biology of protooncogenes and oncogenic variants, as well as normal processes perturbed in cancer cells. These include chromosomal structures and transcriptional pathways. Participating faculty have primary faculty appointments and laboratory space in the Divisions of Basic Sciences and Human Biology at the Fred Hutchinson Cancer Research Center (FHCRC), or in the Departments of Microbiology and Pathobiology at the University of Washington or the Seattle Biomedical Research Institute. Postdoctoral trainees generally have Ph.D. degrees in molecular or cellular biology or virology, or M.D. degrees with previous research experience in the basic sciences. Predoctoral students will enter through the Molecular and Cellular Biology (MCB) Program, or the Departments of Microbiology or Pathobiology at the University of Washington. All of the predoctoral mentors have appointments in the MCB Program. Each student, regardless of home department, will meet the specific requirements of the Viral Oncology Training Program. All research trainees will participate in the research seminars and/or journal clubs related to the research specialties of the participating faculty and will discuss their research with invited speakers. All trainees will participate in the annual VOTG Research Colloquium. The goal of this program is to train researchers who are highly skilled in both the intellectual and technical aspects of research in basic laboratory approaches to virology and oncology. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009229-28
Application #
6909788
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1983-09-01
Project End
2008-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
28
Fiscal Year
2005
Total Cost
$432,725
Indirect Cost
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Mendoza, Ramon; Miller, A Dusty; Overbaugh, Julie (2013) Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A. J Virol 87:2412-9
Metzger, Michael J; Halperin, Abigail C; Manhart, Lisa E et al. (2013) Association of maternal smoking during pregnancy with infant hospitalization and mortality due to infectious diseases. Pediatr Infect Dis J 32:e1-7
Kwan, Elizabeth X; Foss, Eric J; Tsuchiyama, Scott et al. (2013) A natural polymorphism in rDNA replication origins links origin activation with calorie restriction and lifespan. PLoS Genet 9:e1003329
Morris, Valerie A; Punjabi, Almira S; Wells, Robert C et al. (2012) The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology 428:112-20
Mulkearns, Erin E; Cooper, Jonathan A (2012) FCH domain only-2 organizes clathrin-coated structures and interacts with Disabled-2 for low-density lipoprotein receptor endocytosis. Mol Biol Cell 23:1330-42
Kwan, Elizabeth X; Foss, Eric; Kruglyak, Leonid et al. (2011) Natural polymorphism in BUL2 links cellular amino acid availability with chronological aging and telomere maintenance in yeast. PLoS Genet 7:e1002250
Metzger, Michael J; McConnell-Smith, Audrey; Stoddard, Barry L et al. (2011) Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res 39:926-35
Miller, A D; Metzger, M J (2011) APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines. Gene Ther 18:528-30
Halbert, C L; Metzger, M J; Lam, S-L et al. (2011) Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production. Gene Ther 18:411-7
Goodman, Alan G; Fornek, Jamie L; Medigeshi, Guruprasad R et al. (2009) P58(IPK): a novel ""CIHD"" member of the host innate defense response against pathogenic virus infection. PLoS Pathog 5:e1000438

Showing the most recent 10 out of 72 publications